Patient-reported outcomes in randomized clinical trials: Development of ISOQOL reporting standards

Michael Brundage, Jane Blazeby, Dennis Revicki, Brenda Bass, Henrica De Vet, Helen Duffy, Fabio Efficace, Madeleine King, Cindy L K Lam, David Moher, Jane Scott, Jeff Sloan, Claire Snyder, Susan Yount, Melanie Calvert

Research output: Contribution to journalArticle

Abstract

Purpose: To develop expert consensus on a suite of reporting standards for HRQL outcomes of RCTs. Methods: A Task Force of The International Society of Quality of Life Research (ISOQOL) undertook a systematic review of the literature to identify candidate reporting standards for HRQL in RCTs. Subsequently, a web-based survey was circulated to the ISOQOL membership. Respondents were asked to rate candidate standards on a 4-point Likert scale based on their perceived value in reporting studies in which HRQL was a study outcome (primary or secondary). Results were synthesized into draft reporting guidelines, which were further reviewed by the membership to inform the final guidance. Results: Forty-six existing candidate standards for reporting HRQL results in RCTs were synthesized to produce a 40 item survey that was completed electronically by 161 respondents. The majority of respondents rated all 40 items to be either 'essential' or 'desirable' when HRQL was a primary RCT outcome. Ratings changed when HRQL was a secondary study outcome. Feedback on the survey findings resulted in the Task Force generalizing the guidance to include patient-reported outcomes (PROs). The final guidance, which recommends standards for use in reporting PROs generally, and more specifically, for PROs identified as primary study outcomes, was approved by the ISOQOL Board of Directors. Conclusions: ISOQOL has developed a suite of recommended standards for reporting PRO results of RCTs. Improved reporting of PROs will enable accurate interpretation of evidence to inform patient choice, aid clinical decision making, and inform health policy.

Original languageEnglish (US)
Pages (from-to)1161-1175
Number of pages15
JournalQuality of Life Research
Volume22
Issue number6
DOIs
StatePublished - Aug 2013

Fingerprint

Randomized Controlled Trials
Quality of Life
Research
Outcome Assessment (Health Care)
Advisory Committees
Health Policy
Surveys and Questionnaires
Patient Reported Outcome Measures
Guidelines

Keywords

  • Guidelines
  • Patient-reported outcomes
  • Quality of life
  • Randomized clinical trials
  • Reporting

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Medicine(all)

Cite this

Brundage, M., Blazeby, J., Revicki, D., Bass, B., De Vet, H., Duffy, H., ... Calvert, M. (2013). Patient-reported outcomes in randomized clinical trials: Development of ISOQOL reporting standards. Quality of Life Research, 22(6), 1161-1175. https://doi.org/10.1007/s11136-012-0252-1

Patient-reported outcomes in randomized clinical trials : Development of ISOQOL reporting standards. / Brundage, Michael; Blazeby, Jane; Revicki, Dennis; Bass, Brenda; De Vet, Henrica; Duffy, Helen; Efficace, Fabio; King, Madeleine; Lam, Cindy L K; Moher, David; Scott, Jane; Sloan, Jeff; Snyder, Claire; Yount, Susan; Calvert, Melanie.

In: Quality of Life Research, Vol. 22, No. 6, 08.2013, p. 1161-1175.

Research output: Contribution to journalArticle

Brundage, M, Blazeby, J, Revicki, D, Bass, B, De Vet, H, Duffy, H, Efficace, F, King, M, Lam, CLK, Moher, D, Scott, J, Sloan, J, Snyder, C, Yount, S & Calvert, M 2013, 'Patient-reported outcomes in randomized clinical trials: Development of ISOQOL reporting standards', Quality of Life Research, vol. 22, no. 6, pp. 1161-1175. https://doi.org/10.1007/s11136-012-0252-1
Brundage, Michael ; Blazeby, Jane ; Revicki, Dennis ; Bass, Brenda ; De Vet, Henrica ; Duffy, Helen ; Efficace, Fabio ; King, Madeleine ; Lam, Cindy L K ; Moher, David ; Scott, Jane ; Sloan, Jeff ; Snyder, Claire ; Yount, Susan ; Calvert, Melanie. / Patient-reported outcomes in randomized clinical trials : Development of ISOQOL reporting standards. In: Quality of Life Research. 2013 ; Vol. 22, No. 6. pp. 1161-1175.
@article{f96266cd4a42497ba648f788399eb2a5,
title = "Patient-reported outcomes in randomized clinical trials: Development of ISOQOL reporting standards",
abstract = "Purpose: To develop expert consensus on a suite of reporting standards for HRQL outcomes of RCTs. Methods: A Task Force of The International Society of Quality of Life Research (ISOQOL) undertook a systematic review of the literature to identify candidate reporting standards for HRQL in RCTs. Subsequently, a web-based survey was circulated to the ISOQOL membership. Respondents were asked to rate candidate standards on a 4-point Likert scale based on their perceived value in reporting studies in which HRQL was a study outcome (primary or secondary). Results were synthesized into draft reporting guidelines, which were further reviewed by the membership to inform the final guidance. Results: Forty-six existing candidate standards for reporting HRQL results in RCTs were synthesized to produce a 40 item survey that was completed electronically by 161 respondents. The majority of respondents rated all 40 items to be either 'essential' or 'desirable' when HRQL was a primary RCT outcome. Ratings changed when HRQL was a secondary study outcome. Feedback on the survey findings resulted in the Task Force generalizing the guidance to include patient-reported outcomes (PROs). The final guidance, which recommends standards for use in reporting PROs generally, and more specifically, for PROs identified as primary study outcomes, was approved by the ISOQOL Board of Directors. Conclusions: ISOQOL has developed a suite of recommended standards for reporting PRO results of RCTs. Improved reporting of PROs will enable accurate interpretation of evidence to inform patient choice, aid clinical decision making, and inform health policy.",
keywords = "Guidelines, Patient-reported outcomes, Quality of life, Randomized clinical trials, Reporting",
author = "Michael Brundage and Jane Blazeby and Dennis Revicki and Brenda Bass and {De Vet}, Henrica and Helen Duffy and Fabio Efficace and Madeleine King and Lam, {Cindy L K} and David Moher and Jane Scott and Jeff Sloan and Claire Snyder and Susan Yount and Melanie Calvert",
year = "2013",
month = "8",
doi = "10.1007/s11136-012-0252-1",
language = "English (US)",
volume = "22",
pages = "1161--1175",
journal = "Quality of Life Research",
issn = "0962-9343",
publisher = "Springer Netherlands",
number = "6",

}

TY - JOUR

T1 - Patient-reported outcomes in randomized clinical trials

T2 - Development of ISOQOL reporting standards

AU - Brundage, Michael

AU - Blazeby, Jane

AU - Revicki, Dennis

AU - Bass, Brenda

AU - De Vet, Henrica

AU - Duffy, Helen

AU - Efficace, Fabio

AU - King, Madeleine

AU - Lam, Cindy L K

AU - Moher, David

AU - Scott, Jane

AU - Sloan, Jeff

AU - Snyder, Claire

AU - Yount, Susan

AU - Calvert, Melanie

PY - 2013/8

Y1 - 2013/8

N2 - Purpose: To develop expert consensus on a suite of reporting standards for HRQL outcomes of RCTs. Methods: A Task Force of The International Society of Quality of Life Research (ISOQOL) undertook a systematic review of the literature to identify candidate reporting standards for HRQL in RCTs. Subsequently, a web-based survey was circulated to the ISOQOL membership. Respondents were asked to rate candidate standards on a 4-point Likert scale based on their perceived value in reporting studies in which HRQL was a study outcome (primary or secondary). Results were synthesized into draft reporting guidelines, which were further reviewed by the membership to inform the final guidance. Results: Forty-six existing candidate standards for reporting HRQL results in RCTs were synthesized to produce a 40 item survey that was completed electronically by 161 respondents. The majority of respondents rated all 40 items to be either 'essential' or 'desirable' when HRQL was a primary RCT outcome. Ratings changed when HRQL was a secondary study outcome. Feedback on the survey findings resulted in the Task Force generalizing the guidance to include patient-reported outcomes (PROs). The final guidance, which recommends standards for use in reporting PROs generally, and more specifically, for PROs identified as primary study outcomes, was approved by the ISOQOL Board of Directors. Conclusions: ISOQOL has developed a suite of recommended standards for reporting PRO results of RCTs. Improved reporting of PROs will enable accurate interpretation of evidence to inform patient choice, aid clinical decision making, and inform health policy.

AB - Purpose: To develop expert consensus on a suite of reporting standards for HRQL outcomes of RCTs. Methods: A Task Force of The International Society of Quality of Life Research (ISOQOL) undertook a systematic review of the literature to identify candidate reporting standards for HRQL in RCTs. Subsequently, a web-based survey was circulated to the ISOQOL membership. Respondents were asked to rate candidate standards on a 4-point Likert scale based on their perceived value in reporting studies in which HRQL was a study outcome (primary or secondary). Results were synthesized into draft reporting guidelines, which were further reviewed by the membership to inform the final guidance. Results: Forty-six existing candidate standards for reporting HRQL results in RCTs were synthesized to produce a 40 item survey that was completed electronically by 161 respondents. The majority of respondents rated all 40 items to be either 'essential' or 'desirable' when HRQL was a primary RCT outcome. Ratings changed when HRQL was a secondary study outcome. Feedback on the survey findings resulted in the Task Force generalizing the guidance to include patient-reported outcomes (PROs). The final guidance, which recommends standards for use in reporting PROs generally, and more specifically, for PROs identified as primary study outcomes, was approved by the ISOQOL Board of Directors. Conclusions: ISOQOL has developed a suite of recommended standards for reporting PRO results of RCTs. Improved reporting of PROs will enable accurate interpretation of evidence to inform patient choice, aid clinical decision making, and inform health policy.

KW - Guidelines

KW - Patient-reported outcomes

KW - Quality of life

KW - Randomized clinical trials

KW - Reporting

UR - http://www.scopus.com/inward/record.url?scp=84885176452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885176452&partnerID=8YFLogxK

U2 - 10.1007/s11136-012-0252-1

DO - 10.1007/s11136-012-0252-1

M3 - Article

C2 - 22987144

AN - SCOPUS:84885176452

VL - 22

SP - 1161

EP - 1175

JO - Quality of Life Research

JF - Quality of Life Research

SN - 0962-9343

IS - 6

ER -